{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:52:33Z","timestamp":1785891153589,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1124\/jpet.121.000919","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T17:20:37Z","timestamp":1640020837000},"page":"153-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["RTICBM-74 Is a Brain-Penetrant Cannabinoid Receptor Subtype 1 Allosteric Modulator that Reduces Alcohol Intake in Rats"],"prefix":"10.1016","volume":"380","author":[{"given":"Dennis F.","family":"Lovelock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3961-0901","authenticated-orcid":false,"given":"Thuy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalynn","family":"Van Voorhies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-4358","authenticated-orcid":false,"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6187-8376","authenticated-orcid":false,"given":"Joyce","family":"Besheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.000919_bib1","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1016\/j.bmcl.2010.10.068","article-title":"Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate","volume":"20","author":"Alelyunas","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.121.000919_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002130050326","article-title":"Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors","volume":"132","author":"Arnone","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.121.000919_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2010.03.020","article-title":"Depression-like phenotype following chronic CB1 receptor antagonism","volume":"39","author":"Beyer","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.121.000919_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005353.pub3","article-title":"Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation","author":"Cahill","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/jpet.121.000919_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF03190588","article-title":"Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1\/2 be predicted from in-vivo rat data?","volume":"29","author":"Caldwell","year":"2004","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/jpet.121.000919_bib6","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/jpet.121.000919_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107477","article-title":"The therapeutic potential of second and third generation CB1R antagonists","volume":"208","author":"Cinar","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.121.000919_bib8","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1460-9568.2005.04056.x","article-title":"Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats","volume":"21","author":"Cippitelli","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.121.000919_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12035-007-0017-y","article-title":"The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence","volume":"36","author":"Colombo","year":"2007","journal-title":"Mol Neurobiol"},{"key":"10.1124\/jpet.121.000919_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2004.07.069","article-title":"Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol\u2019s motivational properties in alcohol-preferring rats","volume":"498","author":"Colombo","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.121.000919_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00213-005-0199-9","article-title":"Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats","volume":"183","author":"Economidou","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.121.000919_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.taap.2007.05.008","article-title":"Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol","volume":"223","author":"Economidou","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.121.000919_bib13","first-page":"277","article-title":"Effects of SR141716A on ethanol and sucrose self-administration","volume":"25","author":"Freedland","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/jpet.121.000919_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-2999(99)00170-3","article-title":"Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist","volume":"370","author":"Gallate","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.121.000919_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.21287","article-title":"Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity","volume":"64","author":"Hansen","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.121.000919_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.npp.1301034","article-title":"Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference","volume":"32","author":"Hansson","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.121.000919_bib17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","article-title":"Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms","volume":"111","author":"Heilig","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.121.000919_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjp.0707347","article-title":"PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats","volume":"152","author":"Horswill","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.121.000919_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.npp.1300568","article-title":"CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors","volume":"30","author":"Houchi","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.121.000919_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drugalcdep.2014.08.004","article-title":"Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats","volume":"143","author":"Jing","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.121.000919_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/bmc.1130030109","article-title":"Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry","volume":"3","author":"Johansson","year":"1989","journal-title":"Biomed Chromatogr"},{"key":"10.1124\/jpet.121.000919_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/pr.108.000992","article-title":"Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery","volume":"62","author":"Kenakin","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.121.000919_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-28720-6_129","article-title":"Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder","volume":"13","author":"Koob","year":"2013","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/jpet.121.000919_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1126\/science.179.4071.391","article-title":"Delta-9-tetrahydrocannabinol: localization in body fat","volume":"179","author":"Kreuz","year":"1973","journal-title":"Science"},{"key":"10.1124\/jpet.121.000919_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1876523800902020040","article-title":"Suppressing effect of the cannabinoid CB1 receptor antagonist, rimonabant, on alcohol self-administration in alcohol-preferring rats","volume":"2","author":"Maccioni","year":"2009","journal-title":"Open Neuropsychopharmacol J"},{"key":"10.1124\/jpet.121.000919_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108337","article-title":"Central amygdala mineralocorticoid receptors modulate alcohol self-administration","volume":"181","author":"Makhijani","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.121.000919_bib27","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/j.1530-0277.2008.00786.x","article-title":"Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats","volume":"32","author":"Malinen","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/jpet.121.000919_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.beem.2008.09.003","article-title":"Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression","volume":"23","author":"Moreira","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1124\/jpet.121.000919_bib29","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1021\/acs.jmedchem.7b00707","article-title":"Novel diarylurea based allosteric modulators of the cannabinoid CB1 Receptor: evaluation of importance of 6-pyrrolidinylpyridinyl substitution","volume":"60","author":"Nguyen","year":"2017","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.121.000919_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/med.21418","article-title":"Allosteric modulation: an alternate approach targeting the cannabinoid CB1 receptor","volume":"37","author":"Nguyen","year":"2017","journal-title":"Med Res Rev"},{"key":"10.1124\/jpet.121.000919_bib31","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2174\/1568026619666190708164841","article-title":"Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: current approaches for therapeutics development","volume":"19","author":"Nguyen","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/jpet.121.000919_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113068","article-title":"Increased alcohol self-administration following exposure to the predator odor TMT in active coping female rats","volume":"402","author":"Ornelas","year":"2021","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.121.000919_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrn4004","article-title":"Endocannabinoid signalling in reward and addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.121.000919_bib34","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/mol.105.016162","article-title":"Allosteric modulation of the cannabinoid CB1 receptor","volume":"68","author":"Price","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.121.000919_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2017.03.005","article-title":"Sex differences in alcohol self-administration and relapse-like behavior in Long-Evans rats","volume":"156","author":"Randall","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.121.000919_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/acer.13919","article-title":"The toll-like receptor 3 agonist poly(I:C) induces rapid and lasting changes in gene expression related to glutamatergic function and increases ethanol self-administration in rats","volume":"43","author":"Randall","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/jpet.121.000919_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(02)01594-7","article-title":"Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats","volume":"443","author":"Serra","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.121.000919_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1369-1600.2010.00299.x","article-title":"Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats","volume":"17","author":"Vinod","year":"2012","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.121.000919_bib39","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/syn.20533","article-title":"Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice","volume":"62","author":"Vinod","year":"2008","journal-title":"Synapse"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.000919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:25:51Z","timestamp":1739953551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524002416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022356524002416"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.000919","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.13.460113","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RTICBM-74 Is a Brain-Penetrant Cannabinoid Receptor Subtype 1 Allosteric Modulator that Reduces Alcohol Intake in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.000919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}